This study examines the viability of Support Vector Machine (SVM) calculations in tumour classification and survival forecast utilizing multi-omics information investigation in cancer patients. Leveraging a comprehensive dataset comprising genomic, transcriptomic, proteomic, and metabolomics profiles from assorted cancer sorts, we compared four SVM variations: Direct SVM, Polynomial SVM, Radial Basis Function (RBF) SVM, and Sigmoid SVM. Results illustrated that the RBF SVM calculation displayed predominant execution in tumour classification, accomplishing an exactness of 92%, with accuracy, review, and F1 score values of 91%, 94%, and 92% respectively. For survival forecast, the RBF SVM too beat other variations with a concordance file (C-Index) of 78%. These discoveries highlight the potential of SVM approaches in leveraging multi-omics information to move forward with cancer determination and forecast. Our consideration contributes to the developing body of research in machine learning-based cancer investigation and underscores the significance of coordination of different atomic datasets for personalized oncology.
No takes yet. Share an insight, caveat, or question.
Vijay Kumar (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: